Shopping Cart
- Remove All
- Your shopping cart is currently empty
LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2]
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 μg | $333 | 35 days | |
50 μg | $628 | 35 days | |
100 μg | $1,180 | 35 days |
Description | LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2] |
Alias | LTF4 |
Molecular Weight | 568.72 |
Formula | C28H44N2O8S |
Cas No. | 83851-42-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMF: >50 mg/mL (per Ramki Iyer) Ethanol: >50 mg/mL (per Ramki Iyer) DMSO: >50 mg/mL (per Ramki Iyer) |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.